248 related articles for article (PubMed ID: 28395289)
1. Urinary Angiotensinogen and Renin Excretion are Associated with Chronic Kidney Disease.
Juretzko A; Steinbach A; Hannemann A; Endlich K; Endlich N; Friedrich N; Lendeckel U; Stracke S; Rettig R
Kidney Blood Press Res; 2017; 42(1):145-155. PubMed ID: 28395289
[TBL] [Abstract][Full Text] [Related]
2. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
[TBL] [Abstract][Full Text] [Related]
4. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
5. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
[TBL] [Abstract][Full Text] [Related]
6. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
8. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
[TBL] [Abstract][Full Text] [Related]
9. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
10. Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus.
Ba Aqeel S; Ye M; Wysocki J; Sanchez A; Khattab A; Lores E; Rademaker A; Gao X; Bebu I; Nelson RG; Molitch M; Batlle D;
Physiol Rep; 2019 Oct; 7(19):e14242. PubMed ID: 31605461
[TBL] [Abstract][Full Text] [Related]
11. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
Tiryaki Ö; Usalan C; Sayiner ZA
Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
[TBL] [Abstract][Full Text] [Related]
13. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
[TBL] [Abstract][Full Text] [Related]
14. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
[TBL] [Abstract][Full Text] [Related]
15. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors.
Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Suzuki T; Tsuji T; Otsuka A; Kato A; Miyake H; Yasuda H
Intern Med; 2019 Mar; 58(5):643-648. PubMed ID: 30333423
[TBL] [Abstract][Full Text] [Related]
16. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
17. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
Xu Z; Xu B; Xu C
Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
[TBL] [Abstract][Full Text] [Related]
18. Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease.
Ishigaki S; Ohashi N; Aoki T; Matsuyama T; Isobe S; Sato T; Fujikura T; Kato A; Yasuda H
Intern Med; 2021 Jul; 60(14):2201-2206. PubMed ID: 33612680
[TBL] [Abstract][Full Text] [Related]
19. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
